Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against <i>Leishmania tropica</i> (HTD<sub>7</sub>)
Leishmaniasis is affirmed as a category one disease (most emerging and unmanageable) by the World Health Organization (WHO), affecting 98 countries with an annual global incidence of ~1.2 million cases. Options for chemotherapeutic treatment are limited due to drug resistance and cytotoxicity. Thus,...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-08-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/15/8/1005 |
